Pulmatrix, CFFT partner to advance PUR118 clinical trials
According to the agreement, Pulmatrix will receive $1.4m in upfront and milestone-driven funding for the effort from the CFFT, along with introductions to cystic fibrosis academic researchers and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.